Abiopharma

Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results

Total Voting Rights and Capital

SES AI Enters into Framework Agreement with Doroni Aerospace to Design and Develop a Battery Pack for Doroni Aerospace’s H1-X Personal eVTOL

Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors

Change - Change in Corporate Information: Change of Address of Registered Office and Principal Share Registrar in Bermuda

OwlTing Group (NASDAQ: OWLS) Reports OwlPay Harbor July Payment Volume Increased 107.6% Month Over Month

Veritasium Goes Behind the Scenes at Kraig Biocraft Laboratories to Explore the Future of Commercial Spider Silk

REGENXBIO to Host Conference Call on August 6 to Discuss Second Quarter 2026 Financial Results and Operational Highlights

Avista Corp. Reports Q2 2026 Financial Results, Confirms 2026 Utility Earnings Guidance

Publication date of financial statements as of 30.6.26 on 10.8.26, conference call on 13.8.26 at 9:30